Effect of Genetic Polymorphisms of ABCB1, ABCG2, and SLC22A1 on the Steady-State Plasma Concentrations of Lamotrigine in Treatment-Resistant Depressed Patients Treated With Lamotrigine Augmentation Therapy
The present study suggests that these genetic polymorphisms do not play a role in controlling the Css of lamotrigine in treatment-resistant depressed patients treated with lamotrigine augmentation therapy.
Authors
- Kazuo Mihara (ORCID: https://orcid.org/0000-0002-2990-3874)
- Takeshi Suzuki (ORCID: https://orcid.org/0000-0001-8192-1589)
- Yoko Tomori (ORCID: https://orcid.org/0000-0002-6280-0754)
- Kenji Nemoto (ORCID: https://orcid.org/0000-0002-1210-5833)
- A. Nakamura (ORCID: https://orcid.org/0000-0003-3629-9537)
- Tsuyoshi Kondo (ORCID: https://orcid.org/0000-0002-8592-6288)
- Shoko Kagawa (ORCID: https://orcid.org/0000-0001-6994-6687)
- Goyo Nagai (ORCID: https://orcid.org/0000-0002-0646-4039)
Institutions
- University of the Ryukyus (JP)
- Moscow Research and Clinical Center for Neuropsychiatry (RU)
Publication Details
- Journal
- Clinical Neuropharmacology
- Published
- 2024-08-20
- DOI
- https://doi.org/10.1097/wnf.0000000000000607
- Citations
- 3
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.33